New listicle: Five tips on scaling up IVT for mRNA production

The success of messenger RNA or mRNA vaccines in the fight against the global SARS-CoV-2 crisis brings a new era of vaccine development. In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. By partnering with a supplier like Thermo Fisher Scientific, you gain access to end-to-end mRNA workflow solutions, products with proven quality, and technical professionals who can proficiently support you throughout your process development and scale-up stages.

Consider these five measures to help you ensure consistency in your workflow and obtain reproducible, high-quality batches of IVT mRNA at scale, and read the full article here.

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free